Span-America Declares Quarterly Cash Dividend

Marks 104th Consecutive Quarterly Dividend Payment

GREENVILLE, S.C.--(BUSINESS WIRE)-- Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced today that the Board of Directors declared a quarterly cash dividend of $0.16 per share. The dividend is payable December 15, 2015, to shareholders of record on November 30, 2015.

“This quarter’s cash dividend marks the 104th consecutive quarter of paying cash dividends by Span-America,” stated Jim Ferguson, president and chief executive officer of Span-America. “This dividend also represents a 6.7% increase over the cash dividend paid this time last year and highlights our Board’s commitment in building long-term shareholder value through our cash dividend program.”

About Span-America Medical Systems, Inc.

Span-America manufactures and markets a comprehensive selection of pressure management products for the medical market, including Geo-Matt®, PressureGuard®, Geo-Mattress®, Custom Care®, Span+Aids®, Isch-Dish®, Risk Manager® and Selan® products. We also supply custom foam and packaging products to the consumer and industrial markets. Through our wholly-owned subsidiary Span Medical Products Canada Inc., we manufacture and market the M.C. Healthcare Products brands of Encore™, Maxxum, Advantage and Rexx bed frames as well as related case goods, tables and seating products for the long-term care market. Span-America’s stock is traded on The NASDAQ Global Market under the symbol “SPAN.” For more information, visit www.spanamerica.com and www.mchealthcare.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151120005077/en/

Span-America Medical Systems, Inc.
Jim Ferguson, 864-288-8877, ext. 6912
President and Chief Executive Officer

Source: Span-America Medical Systems, Inc.

You May Also Be Interested In

• Golar LNG Limited Interim results for the period ended June 30, 2026
• Kraken Robotics Schedules Q2 2026 Financial Results Release and Webcast
• Yesway, Inc. Reports Second Quarter 2026 Financial Results